Registration number: SC389121

Scotvet Animal Health Ltd

Contents

Abridged Balance Sheet	1 to 2
Notes to the Unaudited Abridged Financial Statements	3 to 5

Scotvet Animal Health Ltd

(Registration number: SC389121)
Abridged Balance Sheet as at 30 September 2024

	Note	2024 £	2023 £
Fixed assets
Intangible assets	4	94,121	107,567
Tangible assets	5	754,342	769,859
Other financial assets		-	2
		848,463	877,428
Current assets
Stocks		26,033	26,428
Debtors		17,017	20,787
Cash at bank and in hand		187,671	120,651
		230,721	167,866
Creditors: Amounts falling due within one year	6	(523,805)	(532,923)
Net current liabilities		(293,084)	(365,057)
Total assets less current liabilities		555,379	512,371
Creditors: Amounts falling due after more than one year	7	(259,245)	(412,298)
Provisions for liabilities		(69,904)	(13,623)
Net assets		226,230	86,450
Capital and reserves
Called up share capital		30	30
Profit and loss account		226,200	86,420
Total equity		226,230	86,450

Scotvet Animal Health Ltd

(Registration number: SC389121)
Abridged Balance Sheet as at 30 September 2024

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 16 March 2025 and signed on its behalf by:
 

Mr A Cant

Director

Mr R Norquay

Director

Scotvet Animal Health Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2024

1	General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
Insa-Bi-Seatter
Dounby
Birsay
Orkney
KW17 2LP

These financial statements were authorised for issue by the Board on 16 March 2025.

2	Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis. Of the company's current liabilities at 30 September 2024, an amount is owed to the director, who has agreed to continue to support the company, and not to demand repayment of this amount to the extent that any such repayment would jeopardise the future of the company.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Freehold property	2% straight line
Fixtures and fittings	10% reducing balance
Leasehold improvements	20% straight line

Scotvet Animal Health Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2024

Goodwill

Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	5% straight line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year was 20 (2023 - 19).

4	Intangible assets

	Total £
Cost or valuation
At 1 October 2023	268,919
At 30 September 2024	268,919
Amortisation
At 1 October 2023	161,352
Amortisation charge	13,446
At 30 September 2024	174,798
Carrying amount
At 30 September 2024	94,121
At 30 September 2023	107,567

Scotvet Animal Health Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 September 2024

5	Tangible assets

	Total £
Cost or valuation
At 1 October 2023	932,087
Additions	11,933
At 30 September 2024	944,020
Depreciation
At 1 October 2023	162,228
Charge for the year	27,450
At 30 September 2024	189,678
Carrying amount
At 30 September 2024	754,342
At 30 September 2023	769,859

6	Creditors: amounts falling due within one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £16,700 (2023 - £20,400).

7	Creditors: amounts falling due after more than one year

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £259,244 (2023 - £412,298).